Speaker Profile
M.D., Ph.D., Neonatal Molecular Precision Medicine and Disease Resilience, Stanford University School of Medicine
Biography
Lawrence (Lance) Prince, MD, PhD, is the Division Chief for Neonatal and Developmental Medicine at Stanford. Dr. Prince’s research interests include the molecular and cellular mechanisms controlling lung development and the maturation of the fetal and neonatal immune systems. He has a particular clinical interest in managing and treating neonatal lung diseases, especially bronchopulmonary dysplasia (BPD) in babies born extremely preterm. Dr. Prince’s research team focuses primarily on the development of innate immunity during fetal life as it impacts health and disease in preterm infants. The laboratory is investigating how microbes including Group B streptococcus exploit the unique features of neonatal macrophages to avoid immune detection and cause disease, as well as leading a number of clinical and translational investigations.
Talk
Neonatal Molecular Precision Medicine and Disease Resilience
While the complications of extreme prematurity can be devastating, many patient have excellent outcomes. In studying the molecular basis for the chronic lung disease bronchopulmonary dysplasia, we identified programs of gene expression correlating with disease protection or resilience. We hope that future genomic studies will help identify therapies that will help achieve normal human development.
Session Abstract – PMWC 2022 Silicon Valley
Track Chairs:
Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine
Kate Kernan, UPMC
The rapid development of genomic sequencing technologies has decreased the cost of genetic analysis to the extent that it seems plausible that genome-scale sequencing could have widespread availability in pediatric care. Genomic sequencing provides a powerful diagnostic modality for patients who manifest symptoms of monogenic disease and an opportunity to detect health conditions before their development. However, many technical, clinical, ethical, and societal challenges should be addressed before such technology is widely deployed in pediatric practice.
Sessions:
- PMWC 2022 Luminary Award Ceremony
- Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine
- Martin Reese, Fabric Genomics - NICU Current State & Future of Whole Genome Sequencing
- Stephen Kingsmore, Rady Children’s Institute for Genomic Medicine - Digital Transformation of Precision Medicine Pathways: A NICU Case Study
- Vasu Rangadass, L7 - Inborn Errors of Immunity in Pediatric Sepsis
- Kate Kernan, UPMC - Neonatal Molecular Precision Medicine and Disease Resilience
- Lawrence Prince, Stanford - Showcase
- Martin Reese, Fabric Genomics
- Madhuri Hegde, PerkinElmer
- Paul Kruszka, GeneDx
- Russell Nofsinger, Rady Children's Inst.
